Combined therapy with bleomycin against malignant melanomas and testicular tumors.
D000008:Abdominal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D001761:Bleomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009362:Neoplasm Metastasis; D013724:Teratoma / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D013736:Testicular Neoplasms / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins; D001761:Bleomycin; D008130:Lomustine